Study Group: Parkinson's Disease Neurologists (US)(?)
Council Members in this Study Group: 105
Request a survey with this Study Group
Leading Experts in this Study Group
Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Neurologists (US) | 1076 |
| Neurologists | 1817 |
| Movement Disorder Neurologists (US) | 141 |
| Attending-Level Neurologists at Academic Medical Centers (US) | 554 |
| Neurologists who Treat Alzheimer's Disease (US) | 191 |
| Neurologists who Treat Epilepsy (US) | 323 |
| Multiple Sclerosis Neurologists (US) | 139 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This large study shows that PD patients' severity of motor dysfunction is better on rasagiline than on placebo.
Medications used for realistic indications and with clinically appropriate symptomatic targets are indicated and provide effectiveness that additional staff cannot offer. Decision making in health care is too often made by those who do not really provide clinical service but provide arm chair...
Extavia, Novartis' brand of interferon beta 1b, has been approved for the treatment of multiple sclerosis by the European Union. With FTY72, Fingolimod, Novartis has the eye on filing NDA by the end of 2009. While essentially identical to Bayer's Betaferon interferon beta 1b,...
The data on ABT-089 in adults has been released with positive results, whereas the adolescent/childhood trial is on-going for this novel compound for ADHD. The key difference is the potential to improve learning, not simply regain attention and lessen hyperactivity.
Copaxone has become the leading treatment for relapsing remitting MS in the US. The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Physician - Division Head
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms